Pawar Kasturi
Exelixis Inc. Alameda, CA, USA 94502.
Adv Pharm Bull. 2023 Jan;13(1):1-4. doi: 10.34172/apb.2023.001. Epub 2022 May 6.
Recent coronavirus pandemic and its global socio-economic impact has re-emphasized the need for safe, fast, and efficient delivery of vaccines for humankind. With advent of technological advances, and to improve patient acquiescence, several techniques for fast, effective, and safe delivery of vaccines have been researched and published in the literature in last three decades. These delivery enhancement techniques include but are not limited to electroporation, microneedles (MN), ultrasound, iontophoresis, etc. This review aims at discussing the current research undergoing in vaccine delivery, specifically focusing on microneedles assisted, the historical background of microneedles and their introduction to drug delivery area, and a special focus on formulation challenges and stability in these systems. The review also sheds light on regulatory challenges one must keep in mind for bringing a successful microneedles-based vaccine delivery into market as well as a snapshot of current commercially available microneedles-based products in cosmetic and pharmaceutical industry.
近期的冠状病毒大流行及其对全球社会经济的影响再次凸显了为人类安全、快速且高效地接种疫苗的必要性。随着技术进步的出现,为了提高患者的接受度,在过去三十年里,人们对多种快速、有效且安全的疫苗接种技术进行了研究并发表在文献中。这些接种增强技术包括但不限于电穿孔、微针(MN)、超声、离子电渗疗法等。本综述旨在讨论疫苗接种领域正在进行的当前研究,特别关注微针辅助接种,微针的历史背景及其在药物递送领域的引入,以及特别关注这些系统中的制剂挑战和稳定性。该综述还阐明了将基于微针的成功疫苗接种推向市场时必须牢记的监管挑战,以及化妆品和制药行业中当前基于微针的商业可用产品的概况。